medmix AG/Fr. MEDX
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About medmix AG
medmix AG is a precision delivery device company operating primarily in the healthcare and industrial sectors. Its core business involves developing and manufacturing high-precision delivery devices used in a variety of applications, including healthcare, consumer, and industrial segments. The company offers a range of products such as drug delivery devices, dental applicators, and industrial mixing solutions. Headquartered in Switzerland, medmix has a global presence with a network that supports its diverse client base. The company focuses on leveraging its expertise in high-precision engineering to offer innovative solutions that meet specific industry needs.
Ticker
Fr. MEDX
Sector
Primary listing
XSWX
Employees
2,574
Headquarters
Baar, Switzerland
Website
medmix AG Metrics
BasicAdvanced
CHF 352M
57.33
CHF 0.15
0.86
CHF 0.50
5.81%
Price and volume
Market cap
CHF 352M
Beta
0.86
52-week high
CHF 13.02
52-week low
CHF 8.16
Average daily volume
86K
Dividend rate
CHF 0.50
Financial strength
Current ratio
1.543
Quick ratio
1.02
Long term debt to equity
72.736
Total debt to equity
77.264
Dividend payout ratio (TTM)
234.38%
Interest coverage (TTM)
2.71%
Profitability
EBITDA (TTM)
72.9
Gross margin (TTM)
36.14%
Net profit margin (TTM)
1.43%
Operating margin (TTM)
6.47%
Effective tax rate (TTM)
21.35%
Revenue per employee (TTM)
CHF 170,000
Management effectiveness
Return on assets (TTM)
1.90%
Return on equity (TTM)
1.59%
Valuation
Price to earnings (TTM)
57.334
Price to revenue (TTM)
0.783
Price to book
0.83
Price to tangible book (TTM)
6.31
Price to free cash flow (TTM)
13.133
Free cash flow yield (TTM)
7.61%
Free cash flow per share (TTM)
0.655
Dividend yield (TTM)
5.81%
Forward dividend yield
5.81%
Growth
Revenue change (TTM)
-7.42%
Earnings per share change (TTM)
-182.66%
3-year revenue growth (CAGR)
-2.08%
3-year earnings per share growth (CAGR)
-18.78%
3-year dividend per share growth (CAGR)
-41.52%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for medmix AG stock?
medmix AG (MEDX) has a market cap of Fr.352M as of April 04, 2026.
What is the P/E ratio for medmix AG stock?
The price to earnings (P/E) ratio for medmix AG (MEDX) stock is 57.33 as of April 04, 2026.
Does medmix AG stock pay dividends?
Yes, the medmix AG (MEDX) stock pays dividends to shareholders. As of April 04, 2026, the dividend rate is Fr.0.5 and the yield is 5.81%. medmix AG has a payout ratio of 234.38% on a trailing twelve-month basis.
When is the next medmix AG dividend payment date?
The next medmix AG (MEDX) dividend payment is scheduled for April 22, 2026.
What is the beta indicator for medmix AG?
medmix AG (MEDX) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.